<DOC>
	<DOCNO>NCT00005812</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . PURPOSE : Phase II trial study effectiveness temozolomide treat patient leptomeningeal metastasis solid tumor lymphoma .</brief_summary>
	<brief_title>Temozolomide Treating Patients With Leptomeningeal Metastases From Solid Tumor Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : - Determine objective response rate , survival time , quality life patient leptomeningeal metastasis solid tumor lymphoma treat oral temozolomide . - Determine adverse event related regimen patient population . - Measure temozolomide concentration CSF serum correlate appropriate pharmacodynamic parameter ( e.g. , response ) patient . OUTLINE : Patients receive oral temozolomide daily 6 week . Courses repeat every 10 week absence unacceptable toxicity disease progression . Patients complete response ( CR ) receive 2 additional course achieve CR . Patients CR except residual radiographic abnormality persist unchanged 2 full course continue 4 course past best response . Quality life assess baseline , weekly first 4 week therapy , monthly thereafter . PROJECTED ACCRUAL : A total 14-24 patient accrue study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Meningeal Carcinomatosis</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Documented leptomeningeal metastasis Carcinomatous meningitis previously untreated failed prior therapy OR Lymphomatous meningitis Systemic disease respond stable current therapy eligible discontinuing therapy would deleterious Age 18 Karnofsky Performance Status 60100 % Life expectancy least 6 week Absolute neutrophil count great 1,500/μL Platelet count great 100,000/μL Creatinine great 2.0 mg/dL No congestive heart failure No unstable angina Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No contraindication diagnostic sampling CSF via lumbar puncture reservoir No medical condition would interfere absorption oral medication ( e.g. , malabsorption , obstruction , frequent vomit ) No uncontrolled infection Prior neuroaxis chemotherapy ( lumbar puncture , reservoir , systemic ) allow No concurrent chemotherapy sit disease No prior radiotherapy area measurable meningeal disease unless clear radiographic progression area No prior radiotherapy great 30 % bone marrow Prior radiotherapy neuroaxis allow No concurrent radiotherapy sit disease progressive disease Recovered prior recent therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>leptomeningeal metastasis</keyword>
	<keyword>temozolomide</keyword>
</DOC>